Etaracizumab Biosimilar

REQUEST MORE INFO
Catalogue No: abx831128
Price: US$435.00
(Size: 100 µg)

Orders to United States ship from United States

Click on the image to see the image legend

Available Options

* Size:




Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Etaracizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGAV/ITGB3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.

Target ITGAV/ITGB3
Research Area Humanized Monoclonal Antibodies, Biosimilars
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1-ND
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
Buffer 0.01 M PBS, pH 7.4.
CAS Number 892553-42-3
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on ITGAV/ITGB3


Write a review

Tags:
(Click to show)